Association Between Diabetes Medications and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis

Association Between Diabetes Medications and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis

Background: Diabetes mellitus (DM) increases the risk of Parkinson's disease (PD). However, whether DM medications play a part on that increased PD risk is unclear. We designed this meta-analysis to assess the influence of different oral DM medications on the PD risk in patients with DM.Methods...

Full description

Bibliographic Details
Main Authors: Xiaocui Qin, Xia Zhang, Pinyu Li, Min Wang, Li Yan, Zeqing Bao, Qili Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Neurology
Subjects:
metformin
dipeptidyl peptidase-4 inhibitors
glucagon-like peptide-1 agonists
glitazones
sulfonylureas
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.678649/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.678649/full

Similar Items